Skip to main content

Table 2 Clinical characteristics of the patients according to the presence or absence of endoscopic Barrett's esophagus.

From: Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease

  Endoscopic BE  
  Negative (n = 94) Positive (n = 69) P-value
Patients profiles    
   Age    
   median; range (years) 60; 23–80 60; 30–77 0.8825*
   Sex    
   Female (%) 48 (51.1) 32 (46.4) 0.5542**
   BMI    
   median; range 24.1; 19.2–39.7 25.8; 19.2–43.6 0.1354*
Endoscopic results    
   Hiatal hernia (%) 11 (11.7) 30 (43.5) <0.0001**
   Erosive esophagitis (%) 13 (13.8) 21 (30.4) 0.0099**
Abdominal surface area    
   VAT (cm2) 97.45 (19.9–514.2) 120.2 (27.6–398.8) 0.0089*
   SAT (cm2) 158.15 (34.5–428.7) 180.4 (35.2–484.8) 0.3169*
Circulating factors secreted from adipocytes    
   Leptin (ng/mL) 9.45 (2.5–27.6) 12.15 (2.7–26.4) 0.5058*
   Adiponectin (μg/mL) 7.9 (3.2–21.4) 5.6 (3.2–12.5) 0.0089*
Other laboratory parameters    
   AST (U/L) 24 (12–112) 27 (12–204) 0.0789*
   ALT (U/L) 30 (4–198) 32 (11–258) 0.0645*
   CHE (U/L) 341 (208–719) 372 (198–545) 0.0225*
   HDL (mg/dL) 57 (23–106) 50 (28–93) 0.1158*
   LDL (mg/dL) 125.5 (40–202) 125 (61–241) 0.7548*
   TG (mg/dL) 120 (50–524) 145 (52–809) 0.1076*
   HOMA-R 2.444 (0.578–26.929) 3.184 (1.102–13.743) 0.3538*
  1. *Mann-Whitney U test, **Chi square test.